{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T23:31:12Z","timestamp":1780961472835,"version":"3.54.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Sexual dysfunction (SD) due to Selective Serotonin Reuptake Inhibitors (SSRI) use is a common condition encountered by psychiatrists and its etiology has not been fully elucidated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>To determine the relationship between alpha Melanocyte Stimulating Hormone (\u03b1-MSH) and Melanocortin-4 receptor (MCR4) levels and sexual function levels of patients with and without SSRI related SD and control group and to examine whether \u03b1-MSH and MCR4 play a role in the etiology of SSRI related SD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A total of 92 patients and 49 healthy volunteers who applied to psychiatry outpatient clinic were included in the study. Sociodemographic form, sexual history form, Structured Clinical Interview for DSM 5, Psychotropic Related Sexual Dysfunction-Turkish version (PreSexDQ-T), Arizona Sexual Experiences Scale, Beck Depression and Anxiety Inventory were used in the evaluation interview with the referred patients. Patient groups were formed according to whether there was SSRI related SD according to the sexual history and PreSexDQ-T scale.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Outcomes<\/jats:title>\n                  <jats:p>The \u03b1-MSH and MCR4 levels were significantly lower in patients with SD due to SSRI use.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>\u03b1-MSH and MCR4 levels were lower in the SSRI related SD (SSRI-SD (+)) group than in the not experiencing SD with SSRIs (SSRI-SD (\u2013)) and control groups. The mean \u03b1-MSH and MCR4 value of the control group was found to be significantly higher than the SSRI-SD (+) patient group, the mean MCR4 value of the control group was found to be significantly higher than the mean MCR4 value of the SSRI-SD (\u2013) patient group. The mean MCR4 and a-MSH values of the SSRI-SD(+) group using SSRI with fluoxetine were significantly lower than the SSRI-SD (\u2013) group using SSRI with fluoxetine.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical implications<\/jats:title>\n                  <jats:p>There is a role for \u03b1-MSH and MCR4 in SSRI related SD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Strengths and limitations<\/jats:title>\n                  <jats:p>Its strength is that it is the first human study in this field. Limitations include small sample size and unknown baseline levels of \u03b1-MSH and MCR4.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The fact that \u03b1-MSH and MCR4 play a role in the etiology of SD due to SSRI use in woman and that there was a significant difference between SSRI-SD (+) and SSRI-SD (\u2013) groups when \u03b1-MSH and MCR4 levels were compared in fluoxetine users supports the hypothesis that serotonin may mediate SD via \u03b1-MSH and MCR4 through 5-hydroxytryptamine-2C (5-HT2C) antagonism.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/sexmed\/qfae085","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T09:09:36Z","timestamp":1734685776000},"source":"Crossref","is-referenced-by-count":1,"title":["Comparison of melanocortin-4 reptor and \u03b1-melanoside stimulated hormone levels in healthy female volunteers and female patients with and without sexual functional disorders related to the use of selective serotonin reaptake inhibitors"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9659-1954","authenticated-orcid":false,"given":"Simge N","family":"Kurt Kaya","sequence":"first","affiliation":[{"name":"Department of Psychiatry , 29 May\u0131s State Hospital, Ankara, 06105 ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3196-5089","authenticated-orcid":false,"given":"Yasir","family":"Safak","sequence":"additional","affiliation":[{"name":"Department of Psychiatry , Etlik City Hospital, Ankara, 06170 ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8891-5496","authenticated-orcid":false,"given":"Seyda","family":"Ozdemir","sequence":"additional","affiliation":[{"name":"Department of Biochemistry , Etlik City Hospital, Ankara, 06170 ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,12,20]]},"reference":[{"issue":"8","key":"2024122009093201300_ref1","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/OGX.0b013e31817f13e3","article-title":"Female sexual dysfunction in obstetrics and gynecology","volume":"63","author":"Srivastava","year":"2008","journal-title":"Obstet Gynecol Surv"},{"issue":"3","key":"2024122009093201300_ref2","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1093\/schbul\/sbv001","article-title":"The facts about sexual (Dys)function in schizophrenia: an overview of clinically relevant findings","volume":"41","author":"de Boer","year":"2015","journal-title":"Schizophr Bull"},{"issue":"3","key":"2024122009093201300_ref3","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/inm.12973","article-title":"Sexual dysfunction in people treated with long-acting injectable antipsychotics in monotherapy or polypharmacy: a naturalistic study","volume":"31","author":"Mart\u00ednez-Giner","year":"2022","journal-title":"Int J Ment Health Nurs"},{"issue":"1","key":"2024122009093201300_ref4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/(SICI)1520-6394(1997)6:1&lt;10::AID-DA2&gt;3.0.CO;2-9","article-title":"Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis","volume":"6","author":"Steffens","year":"1997","journal-title":"Depress Anxiety"},{"issue":"5","key":"2024122009093201300_ref5","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1176\/ajp.156.5.807","article-title":"Sexual functioning with selective serotonin reuptake inhibitors","volume":"156","author":"Balon","year":"1999","journal-title":"Am J Psychiatry"},{"key":"2024122009093201300_ref6","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.pbb.2013.10.004","article-title":"Sexual side effects of serotonergic antidepressants: mediated by inhibition of serotonin on central dopamine release?","volume":"121","author":"Bijlsma","year":"2014","journal-title":"Pharmacol Biochem Behav"},{"key":"2024122009093201300_ref7","first-page":"10","article-title":"Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients","volume":"62","author":"Montejo","year":"2001","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"2024122009093201300_ref8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1055\/s-0033-1347177","article-title":"Sexual dysfunction related to psychotropic drugs: a critical review part II: antipsychotics","volume":"46","author":"La Torre","year":"2013","journal-title":"Pharmacopsychiatry"},{"issue":"4","key":"2024122009093201300_ref9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1080\/00926230902851322","article-title":"Effects of SNS activation on SSRI-induced sexual side effects differ by SSRI","volume":"35","author":"Ahrold","year":"2009","journal-title":"J Sex Marital Ther"},{"key":"2024122009093201300_ref10","first-page":"194","article-title":"Mechanism of actions of antidepressants: beyond the receptors","volume":"12","author":"Y\u0131ld\u0131z","year":"2002","journal-title":"Bull Clin Psychopharmacol l"},{"issue":"6","key":"2024122009093201300_ref11","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1111\/j.1743-6109.2009.01309.x","article-title":"Pathways of sexual desire","volume":"6","author":"Pfaus","year":"2009","journal-title":"J Sex Med"},{"issue":"4","key":"2024122009093201300_ref12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3109\/10401239709147804","article-title":"Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction","volume":"9","author":"Labbate","year":"1997","journal-title":"Ann Clin Psychiatry"},{"issue":"4","key":"2024122009093201300_ref13","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrd2331","article-title":"Targeting melanocortin receptors: an approach to treat weight disorders and sexual dysfunction","volume":"7","author":"Wikberg","year":"2008","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"2024122009093201300_ref14","doi-asserted-by":"publisher","first-page":"E468","DOI":"10.1152\/ajpendo.00434.2002","article-title":"The melanocortin system","volume":"284","author":"Gantz","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"2024122009093201300_ref15","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0361-9230(99)00270-1","article-title":"ACTH- and alpha-MSH-induced grooming, stretching, yawning and penile erection in male rats: site of action in the brain and role of melanocortin receptors","volume":"51","author":"Argiolas","year":"2000","journal-title":"Brain Res Bull"},{"issue":"4","key":"2024122009093201300_ref16","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1210\/en.2014-1788","article-title":"Reduced melanocortin production causes sexual dysfunction in male mice with POMC neuronal insulin and leptin insensitivity","volume":"156","author":"Faulkner","year":"2015","journal-title":"Endocrinology"},{"issue":"9","key":"2024122009093201300_ref17","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/j.1365-2826.2006.01465.x","article-title":"Effects of alpha-melanocyte-stimulating hormone on magnocellular oxytocin neurones and their activation at intromission in male rats","volume":"18","author":"Caquineau","year":"2006","journal-title":"J Neuroendocrinol"},{"issue":"2","key":"2024122009093201300_ref18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0304-3940(84)90068-5","article-title":"Serotoninergic endings on VIP-neurons in the suprachiasmatic nucleus and on ACTH-neurons in the arcuate nucleus of the rat hypothalamus. A combination of high resolution autoradiography and electron microscopic immunocytochemistry","volume":"44","author":"Kiss","year":"1984","journal-title":"Neurosci Lett"},{"issue":"1","key":"2024122009093201300_ref19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1749-6632.2003.tb03177.x","article-title":"Central serotonin and melanocortin pathways regulating energy homeostasis","volume":"994","author":"Heisler","year":"2003","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"2024122009093201300_ref20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/cne.903510304","article-title":"Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain","volume":"351","author":"Wright","year":"1995","journal-title":"J Comp Neurol"},{"issue":"1","key":"2024122009093201300_ref21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.sxmr.2017.07.002","article-title":"Post-SSRI sexual dysfunction: a literature review","volume":"6","author":"Bala","year":"2018","journal-title":"Sex Med Rev"},{"issue":"24","key":"2024122009093201300_ref22","doi-asserted-by":"publisher","DOI":"10.1172\/JCI151976","article-title":"Melanocortin 4 receptor stimulation prevents antidepressant-associated weight gain in mice caused by long-term fluoxetine exposure","volume":"131","author":"Ortu\u00f1o","year":"2021","journal-title":"J Clin Invest"},{"issue":"4","key":"2024122009093201300_ref23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.9740\/mhc.2016.07.191","article-title":"Sexual dysfunction in selective serotonin reuptake inhibitors (SSRIs) and potential solutions: a narrative literature review","volume":"6","author":"Jing","year":"2016","journal-title":"Mental Health Clinician"},{"issue":"1","key":"2024122009093201300_ref24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/009262300278623","article-title":"The Arizona sexual experience scale (ASEX): reliability and validity","volume":"26","author":"McGahuey","year":"2000","journal-title":"J Sex Marital Ther"},{"issue":"3","key":"2024122009093201300_ref25a","first-page":"141","article-title":"Psychometric characteristics of the psychotropic-related sexual dysfunction questionnaire. Spanish work group for the study of psychotropic-related sexual dysfunctions","volume":"28","author":"Montejo","year":"2000","journal-title":"Actas Esp Psiquiatr"},{"issue":"6","key":"2024122009093201300_ref25","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","article-title":"An inventory for measuring clinical anxiety: psychometric properties","volume":"56","author":"Beck","year":"1988","journal-title":"J Consult Clin Psychol"},{"issue":"6","key":"2024122009093201300_ref26","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"2024122009093201300_ref27","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1210\/jcem.86.3.7298","article-title":"The melanocortin melanocyte-stimulating hormone\/adrenocorticotropin(4-10) decreases body fat in humans","volume":"86","author":"Fehm","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024122009093201300_ref28","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1080\/00926239708403923","article-title":"SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients","volume":"23","author":"Montejo-Gonz\u00e1lez","year":"1997","journal-title":"J Sex Marital Ther"},{"issue":"1","key":"2024122009093201300_ref29","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1743-6109.2007.00630.x","article-title":"Persistent sexual dysfunction after discontinuation of selective serotonin reuptake inhibitors","volume":"5","author":"Csoka","year":"2008","journal-title":"J Sex Med"},{"issue":"3","key":"2024122009093201300_ref30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1744-6163.2002.tb00665.x","article-title":"Mechanisms and treatments of SSRI-induced sexual dysfunction","volume":"38","author":"Keltner","year":"2002","journal-title":"Perspect Psychiatr Care"}],"container-title":["Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/smoa\/article-pdf\/12\/6\/qfae085\/61242798\/qfae085.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/smoa\/article-pdf\/12\/6\/qfae085\/61242798\/qfae085.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T09:09:38Z","timestamp":1734685778000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/smoa\/article\/doi\/10.1093\/sexmed\/qfae085\/7929252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12,3]]}},"URL":"https:\/\/doi.org\/10.1093\/sexmed\/qfae085","relation":{},"ISSN":["2050-1161"],"issn-type":[{"value":"2050-1161","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,12]]},"article-number":"qfae085"}}